✓
Open
3 Nov 2022
✓
Close
7 Nov 2022
3
Allotment
—
✓
Listing
Wed, Nov 16, 2022
Price Band
₹319 to ₹336
Issue Size
6,56,41,952 shares (agg. up to ₹2,206 Cr)
Lot Size
44 Shares
Listing Date
Wed, Nov 16, 2022
Latest GMP
₹30
Est. Gain
8.93%
✦ AI Insight
GMP Trend
16-11-2022₹30Est. ₹366+8.93%
15-11-2022₹28Est. ₹364+8.33%
14-11-2022₹22Est. ₹358+6.55%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 7.11x |
Restated Financials (₹ Cr.)
| Period Ended | 30 Jun 2022 | 31 Mar 2022 | 31 Mar 2021 | 30 Jun 2020 | 31 Mar 2020 |
|---|---|---|---|---|---|
| Assets | 3,221.94 | 3,145.52 | 2,694.11 | 2,855.11 | 2,666.29 |
| Total Income | 626.54 | 2,205.82 | 1,478.16 | 491.58 | 1,544.27 |
| Profit After Tax | 58.71 | 196.20 | 28.81 | 41.76 | 36.33 |
| NET Worth | 1,675.55 | 1,616.01 | 1,382.34 | 1,425.38 | 1,349.54 |
| Reserves and Surplus | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Borrowing | 794.45 | 837.86 | 644.60 | 725.07 | 621.94 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Rainbow Children's Medicare Ltd. | Mainboard | ₹1,580.85 Cr | ₹542 | 43.53 | ₹450.20 | -16.94% | ₹1,490.80 (-0.72%) |
| Global Longlife Hospital & Research Ltd. | SME | ₹49.00 Cr | ₹140 | 38.04 | ₹135.35 | -3.32% | ₹11.40 (+2.89%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Investment in two of our Subsidiaries, GHPPL and MHPL, in the form of debt or equity for repayment/prepayment of borrowings, in full or part, of such Subsidiaries | 375.00 |
| 2 | General corporate purposes | 101.70 |
About Global Health IPO
Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. Global Health Limited have a network of four hospitals currently in operation (Gurugram, Indore, Ranchi and Lucknow) under the "Medanta" brand. The company established "The Medanta Institutional Tissue Repository" in 2017 to promote biomarker and other tissue-based research. In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, the company generated income from healthcare services of Rs. 14,805.71 million, Rs. 14,178.41 million, Rs. 21,003.95 million, Rs. 4,732.10 million and Rs. 5,960.89 226 million, respectively, and had EBITDA of Rs. 2,304.54 million, Rs. 2,228.52 million, Rs. 4,897.57 million, Rs. 1,057.69 million and Rs. 1,416.46 million, respectively. As of June 30, 2022, the company provide healthcare services in over 30 medical specialities and engage over 1,300 doctors led by experienced department heads, spanning an area
Contact Details
Global Health Ltd. AddressMedanta MediclinicE-18, Defence ColonyNew Delhi, New Delhi, 110024+91 124 483 4060compliance@medanta.orgVisit Website